RxDoctor Payments Data

Krista Radford

Nurse Practitioner · Nashua, NHNPI 1811365307

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,730 of the $2,512 with a category attached, or 68.8%. Novartis accounts for 81.2% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $1,385 and has fallen 92.9% since, to $98 in 2025. Among nurse practitioner clinicians in NH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,512in general payments, 2019–2025

Across 10 payments — averaging $251.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$2K
  • LEO Pharma Inc.$375
  • Lundbeck LLC$33
  • Vanda Pharmaceuticals Inc.$27
  • Otsuka America Pharmaceutical, Inc.$20
  • AbbVie$17

What the payments were for

  • Consulting fees$1,73069%
  • Travel & lodging$68527%
  • Food & beverage$984%

General payments by program year

22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,512 in reported general payments places this provider in the 95th percentile of 714 nurse practitioner providers in New Hampshire.

See all nurse practitioner providers in New Hampshire

Medicare billing

Part B allowed, 2024
$1,825,674
Medicare patients
102
Services billed
43,087

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban36$20,960
JanuviaSitagliptin Phosphate16$8,935
JardianceEmpagliflozin11$6,403
Mirtazapine118$2,644
Duloxetine Hcl29$1,842
Rosuvastatin Calcium31$1,190
Memantine Hcl19$966
Buspirone Hcl18$961
Atorvastatin Calcium93$882
Oxybutynin Chloride ErOxybutynin Chloride12$706
Levothyroxine Sodium45$622
Pantoprazole Sodium22$552
Omeprazole59$535
Metoprolol Succinate31$481
Diclofenac Sodium12$429

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Nashua

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →